Revelation Capital Management, LLC
CIK 1801811 · View on SEC EDGAR ↗
- Portfolio value
- $109.5M
- Positions
- 2
- As of
- June 30, 2026
#8,213 of 9,443 by 13F value · top 87.0%
Portfolio value QoQ: +62.5% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.1
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $7,682,500
- New positions
- 0
- Increased
- 0
- Decreased
- 1
- Closed
- 0
On this page
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Health Care
100.0%
Full portfolio 2 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| OMDA Omada Health, Inc. - Common Stock | $106,633,846 | 97.35% | 4,858,034 | $41,168,859 | Down ×1 | ||
| ARTV Artiva Biotherapeutics, Inc. - Common Stock | $2,903,317 | 2.65% | 299,311 | $975,754 | |||
| No matches | |||||||